Erin J. Aiello Bowles, MPH

home / authors / erin-j-aiello-bowles-mph

Articles

November 20th 2012

Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study

Katrina A.B. Goddard, PhD Erin J. Aiello Bowles, MPH Heather Spencer Feigelson, PhD, MPH Laurel A. Habel, PhD Sharon Hensley Alford, PhD Catherine A. McCarty, PhD, MPH Larissa Nekhlyudov, MD, MPH Adedayo A. Onitilo, MD, MSCR, FACP Alanna K. Rahm, PhD, MS Jennifer A. Webster, MS

Evaluation of real-world implementation of HER2 testing showed that uptake was high (>90%) and trastuzumab treatment was targeted to patients with positive HER2 status.

March 4th 2011

Timing of Follow-up After Abnormal Screening and Diagnostic Mammograms

Karen J. Wernli, PhD Erin J. Aiello Bowles, MPH Sebastien Haneuse, PhD Joanne G. Elmore, MD, MPH Diana S.M. Buist, PhD, MPH

Woman-level characteristics such as breast symptoms at mammography are associated with earlier follow-up within an integrated health system with an active breast health plan.